To assess whether the suppression of tumor growth following CMTM6 knockdown is attributable to a reduction in macrophage-mediated effects, we employed anti-F4/80 (α-F4/80) antibody to deplete macrophages in the TC-1 tumor model. The gene discussed is CMTM6; the disease is neoplasm.